Indo Borax & Chemicals Ltd has initiated a postal ballot process to seek shareholder approval for creating security over its movable and immovable properties, assets, investments, and securities. This authorization is required to secure borrowings and financial facilities up to ₹400 crore from banks and financial institutions.

The proposal falls under Section 180(1)(a) of the Companies Act, 2013. The company intends to allow its Board of Directors to pledge, mortgage, or hypothecate company assets, including shares held in subsidiary Kronox Lab Sciences Limited, to support working capital needs, capital expenditure, and general corporate purposes within the previously approved borrowing limits.

E-voting schedule and eligibility

The remote e-voting period commences on Tuesday, October 13, 2026, at 9:00 am and concludes on Wednesday, November 11, 2026, at 5:00 pm. Members whose names appear in the Register of Members or Beneficial Owners as on the cut-off date of Friday, October 9, 2026, are eligible to vote. Voting rights will be proportional to the paid-up equity share capital held by each member on the cut-off date.

MUFG Intime India Private Limited has been engaged to provide the remote e-voting facility. The notice is being sent exclusively via electronic mode to members with registered email addresses, in compliance with Ministry of Corporate Affairs circulars.

Strategic context for security creation

The explanatory statement highlights that the company recently acquired a controlling interest in Kronox Lab Sciences Limited. As a result, the status of Kronox as a material subsidiary may be determined based on applicable financial thresholds. Consequently, the company seeks this approval to facilitate the pledge of shares held in Kronox, if required by lenders, ensuring flexibility in securing future debt facilities.

What the numbers show

The request aligns precisely with the overall borrowing limit of ₹400 crore previously approved by members under Section 180(1)(c) of the Companies Act, 2013. By seeking a blanket authorization for security creation up to this same limit, Indo Borax aims to streamline future loan acquisitions without requiring individual shareholder approvals for each specific collateral arrangement. This indicates a strategic move to enhance operational agility in raising debt while maintaining compliance with statutory limits.

Scrutiny and declaration

CS Sandhya Malhotra, Partner at M/s. Manish Ghia & Associates, has been appointed as the scrutinizer to ensure a fair and transparent voting process. The results of the postal ballot will be declared within two working days from the conclusion of the e-voting period and communicated to stock exchanges and the company website.

Indo Borax & Chemicals appointed Suresh Kalra as Managing Director and Chief Executive Officer of Kronox Lab Sciences Limited on October 1, 2026, following the completion of its 64.26% equity stake acquisition.

The leadership transition marks a new phase for the specialty chemicals company after the deal closed on September 29, 2026. Shashikant Bharuka was also appointed as Chief Financial Officer and Key Managerial Personnel at Kronox. The move aims to strengthen operational synergies within the newly acquired entity.

Leadership Appointments and Strategic Focus

Suresh Kalra has been appointed for a period of five years. He brings more than 25 years of leadership experience in the chemicals industry, with expertise in global operations, P&L management, manufacturing, and strategic planning across India, the US, Middle East, and Asia Pacific.

Commenting on the appointment, Kalra stated that his focus will be on strengthening operations, expanding capabilities, deepening customer relationships, and pursuing sustainable growth opportunities in domestic and global markets. He noted that Kronox has built a strong foundation in high-purity speciality chemicals supported by its manufacturing capabilities and technical expertise.

Board Reconstitution and Governance

A new Board was constituted with three executive directors and three independent directors, bringing experience across chemicals, manufacturing, finance, banking, legal, and corporate governance. The Board also reconstituted the Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, and Corporate Social Responsibility Committee.

The acquisition involved the purchase of 2,38,44,000 equity shares from sellers Ketan Vinodchandra Ramani, Pritesh Vinodchandra Ramani, and Jogindersingh Gianchand Jaswal. The erstwhile promoters retain a 9.95% stake in Kronox Lab Sciences.

Financial Context and Transaction Details

The acquisition was financed through ₹225 crore in funding availed from an unnamed lending institution. This capital infusion supports Indo Borax's strategic expansion into the laboratory sciences sector. The transaction follows the execution of the share purchase agreement (SPA) on August 20, 2026, with Zenrock Chemicals Private Limited also party to the deal.

Kronox Lab Sciences Limited, incorporated in 2008 and headquartered in Vadodara, Gujarat, manufactures high-purity speciality fine chemicals including excipients, reagents, buffers, and intermediates. The company reported revenue of approximately ₹101 crore and profit after tax of approximately ₹28 crore for FY26.

Regulatory Compliance and Disclosures

Indo Borax filed an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirming the completion of the acquisition and subsequent appointments. The filing references the original intimation dated August 20, 2026, regarding the SPA execution. The company stated that no other details required under Regulation 30 read with Schedule III have changed since the original disclosure. The filing was signed by Pravin Chavan, Company Secretary & Compliance Officer, on October 1, 2026.